Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medulloblastoma.

Catherine A. Mazzola1, Ian F. Pollack

  • 1Department of Neurosurgery, University of Pittsburgh Children's Hospital, 3705 Fifth Avenue, Suite 3705, Third Floor, Pittsburgh, PA 15213, USA. ian.pollack@chp.edu

Current Treatment Options in Neurology
|April 3, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Medulloblastomas are common pediatric brain tumors. Treatment is tailored based on risk factors, intensifying therapy for high-risk patients and reducing radiation for standard-risk patients to improve outcomes and minimize side effects.

Area of Science:

  • Pediatric Oncology
  • Neuro-oncology
  • Molecular Biology

Background:

  • Medulloblastomas are the most common pediatric brain tumors, arising from cerebellar granule cell precursors.
  • Genetic links exist with disorders like Turcot's and Gorlin's syndromes, involving genes in sonic hedgehog pathways.
  • Clinical factors significantly influence outcomes in pediatric medulloblastoma patients.

Purpose of the Study:

  • To analyze clinical factors impacting outcomes in pediatric medulloblastoma.
  • To evaluate risk stratification for tailoring treatment strategies.
  • To improve treatment efficacy and reduce sequelae in high-risk and standard-risk patients.

Main Methods:

  • Analysis of multi-institutional clinical trials.
  • Preoperative and postoperative neuroimaging for staging and residual disease assessment.

Related Experiment Videos

  • Cerebrospinal fluid analysis for leptomeningeal spread detection.

    • Main Results:

    • Younger age, bulky residual disease, and metastasis are adverse prognostic factors for high-risk patients.
    • Standard therapy involves craniospinal and posterior fossa radiation.
    • Chemotherapeutic trials aim to improve outcomes for high-risk patients and reduce radiation for standard-risk patients.

    Conclusions:

    • Treatment is increasingly tailored based on clinical risk factors.
    • Intensified treatment for high-risk and reduced radiation for standard-risk patients are key strategies.
    • Ongoing evaluation of biologic predictors may further refine treatment stratification.